title: Leukaemia update. Part 2: managing patients with leukaemia in the community.
authors.affiliation: Department of Pathology, Division of Molecular Histopathology, University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
authors.forename: Nicholas F
authors.initials: NF
authors.lastname: Grigoropoulos
authors.forename: Roger
authors.initials: R
authors.lastname: Petter
authors.forename: Mars B
authors.initials: MB
authors.lastname: Van 't Veer
authors.forename: Mike A
authors.initials: MA
authors.lastname: Scott
authors.forename: George A
authors.initials: GA
authors.lastname: Follows
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001803:Blood Transfusion; D044504:Enterocolitis, Neutropenic / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D007246:Infertility / Q000139:chemically induced; D007938:Leukemia / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D017410:Practice Guidelines as Topic
chemical_list: D000970:Antineoplastic Agents